Neuroprotective effects of a triple GLP-1/GIP/glucagon receptor agonist in the APP/PS1 transgenic mouse model of Alzheimer's disease - ScienceDirect 2018-01-02T11:20:29+01:00 via https://news.ycombinator.com/item?id=16048069 — Permalink